American Journal of Medicine

Journal

Publication Venue For

  • End-of-Life Spending and Healthcare Utilization Among Older Adults with Chronic Obstructive Pulmonary Disease.  133:817-824.e1. 2020
  • Why Do Residency Program Directors Consider Resigning? A Mixed-Methods Analysis of a National Program Director Survey.  133:761-767. 2020
  • Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study.  133:222-230.e11. 2020
  • Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial.  133:e25-e31. 2020
  • AAIM Recommendations for the 2020-2021 Internal Medicine Residency Application Cycle in Response to the COVID-19 Pandemic 2020
  • COVID-19 Is Disproportionately High in African Americans. This Will Come as No Surprise… 2020
  • Digoxin Initiation and Outcomes in Patients with Heart Failure (HFrEF and HFpEF) and Atrial Fibrillation 2020
  • Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction 2020
  • Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.  133:84-94. 2020
  • Digoxin Use and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.  132:1311-1319. 2019
  • Ideal Cardiovascular Health Among American Adults After the Economic Recession of 2008-2009: Insights from NHANES.  132:1182-1190.e5. 2019
  • Adherence and Outcomes with Urate-Lowering Therapy: A Site-Randomized Trial.  132:354-361. 2019
  • Internal Medicine Residency Program Director Burnout and Program Director Turnover: Results of a National Survey.  132:252-261. 2019
  • Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction.  132:71-80.e1. 2019
  • Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate.  131:1473-1481. 2018
  • Pectus Excavatum and Right Ventricular Compression in a Young Athlete with Syncope.  131:e451-e453. 2018
  • Pneumaturia and Nephrotic Syndrome Caused by a HiddenPelvic Malignancy.  131:e421-e422. 2018
  • The Reply.  131:e263. 2018
  • The Reply.  131:e267-e268. 2018
  • To Reduce Stroke with PFO Closure, Respect the Shunt.  131:e261-e262. 2018
  • Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.  131:575-577. 2018
  • Severe Asthma in Primary Care: Identification and Management.  131:484-491. 2018
  • Gastric Antral Vascular Ectasia and Metabolic Syndrome: Is There a Case for an Association?.  130:e511. 2017
  • Not Your Typical Renal Cyst.  130:e429-e432. 2017
  • An Unusual Presentation of Thrombotic Thrombocytopenic Purpura.  130:e323-e326. 2017
  • An Acquired Factor X Inhibitor: The Importance of Understanding Coagulation.  130:e307-e308. 2017
  • Migraine Headache and Long-Term Cardiovascular Outcomes: An Extended Follow-Up of the Women's Ischemia Syndrome Evaluation.  130:738-743. 2017
  • Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT.  130:439-448.e9. 2017
  • Future of the Palliative Care Workforce: Preview to an Impending Crisis.  130:113-114. 2017
  • Inside Out: Bone Marrow Necrosis and Fat Embolism Complicating Sickle-β+ Thalassemia.  129:e321-e324. 2016
  • Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.  129:1178-1184. 2016
  • Update on Importance of Diet in Gout.  129:1153-1158. 2016
  • Impact of Emergency Department Visits and Hospitalization on Mobility Among Community-Dwelling Older Adults.  129:1124.e9-1124.e15. 2016
  • Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.  129:1067-1073. 2016
  • The Impact of Cardiorespiratory Fitness Levels on the Risk of Developing Atherogenic Dyslipidemia.  129:1060-1066. 2016
  • The Reply.  129:e207-e208. 2016
  • Allopurinol Dose Reductions Based on Creatinine Alert Redesign System.  129:e95. 2016
  • Effects of Extended-Release Niacin Added to Simvastatin/Ezetimibe on Glucose and Insulin Values in AIM-HIGH.  129:753.e13-753.e22. 2016
  • Factors Associated with Declining Residency Program Pass Rates on the ABIM Certification Examination.  129:759-765. 2016
  • A Rare Cause of Large Bowel Obstruction.  129:e11-e12. 2016
  • Practical Management Guide for Clinicians Who Treat Patients with Amiodarone.  129:468-475. 2016
  • Treatment of Hypertension in Patients with Coronary Artery Disease. A Case-Based Summary of the 2015 AHA/ACC/ASH Scientific Statement.  129:372-378. 2016
  • Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician.  129:153-162.e7. 2016
  • Mammography screening among the elderly: A research challenge.  128:1362.e7-1362.e14. 2015
  • The Reply.  128:e43-e44. 2015
  • AACE response to a candid discussion of obesity.  128:e57. 2015
  • Apparent treatment-resistant hypertension among individuals with history of stroke or transient ischemic attack.  128:707-714.e2. 2015
  • Gender differences in salary of internal medicine residency directors: A national survey.  128:659-665. 2015
  • American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function.  128:970-976.e2. 2015
  • Beta-blocker use and 30-day all-cause readmission in medicare beneficiaries with systolic heart failure.  128:715-721. 2015
  • Outcomes of Acute Myocardial Infarction in Patients with Hypertrophic Cardiomyopathy.  128:879-887.e1. 2015
  • The reply.  128:e19. 2015
  • The new internal medicine fellowship match timeline: A change in the right direction.  127:1132-1136. 2014
  • Tuberculosis: Forgetting can be fatal.  127:e3-e4. 2014
  • The reply.  127. 2014
  • Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure.  127:132-139. 2014
  • Coronary subclavian steal syndrome.  127. 2014
  • Depression, dietary habits, and cardiovascular events among women with suspected myocardial ischemia.  127:840-847. 2014
  • Digoxin use and lower 30-day all-cause readmission for medicare beneficiaries hospitalized for heart failure.  127:61-70. 2014
  • Perplexity of a fungus in the sinus.  127:e1. 2014
  • Usefulness of the ACGME resident survey: A view from internal medicine program directors.  127:351-355. 2014
  • The reply.  126. 2013
  • Rate-control versus Rhythm-control Strategies and Outcomes in Septuagenarians with Atrial Fibrillation.  126:887-893. 2013
  • Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure.  126:701-708. 2013
  • Impact of severe mitral regurgitation on postoperative outcomes after noncardiac surgery.  126:529-535. 2013
  • Total antioxidant capacity of diet and risk of heart failure: A population-based prospective cohort of women.  126:494-500. 2013
  • Angiotensin-converting enzyme inhibitors and outcomes in heart failure and preserved ejection fraction.  126:401-410. 2013
  • Saturnine gout, redux: A review.  126. 2013
  • Vitamin K deficiency is associated with incident knee osteoarthritis.  126:243-248. 2013
  • Metanx in type 2 diabetes with peripheral neuropathy: A randomized trial.  126:141-149. 2013
  • Renin-angiotensin inhibition in diastolic heart failure and chronic kidney disease.  126:150-161. 2013
  • Cardiovascular risk in rheumatoid arthritis: Comparing tnf-α blockade with nonbiologic DMARDs.  126:730.e9-730.e17. 2013
  • Challenges with continuity clinic and core faculty accreditation requirements.  126:550-556. 2013
  • Early invasive versus initial conservative treatment strategies in octogenarians with UA/NSTEMI.  126. 2013
  • United states counties with low black male mortality rates.  126:76-80. 2013
  • Total antioxidant capacity from diet and risk of myocardial infarction: A prospective cohort of women.  125:974-980. 2012
  • Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease.  125:399-410. 2012
  • Incidence of cardiovascular events after hospital admission for pneumonia.  124:244-251. 2011
  • Recognizing and Assessing Key Symptom Domains in Chronic Widespread Pain: Focus on Fibromyalgia.  124:S2. 2011
  • Challenges with duty hour reforms: A survey of residency program directors.  124:370-378. 2011
  • Obesity is not protective against fracture in postmenopausal women: Glow.  124:1043-1050. 2011
  • Lung Function in Young Adults Predicts Airflow Obstruction 20 Years Later.  123. 2010
  • Pathophysiology of Fibromyalgia.  122. 2009
  • Introduction: Human Papillomavirus-A Clear, Present, and Common Danger.  122. 2009
  • Gastrointestinal Bleeding: One Complaint, Two Culprits.  122:e3. 2009
  • Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe.  122:S3. 2009
  • The Anticipated Physician Shortage: Meeting the Nation's Need for Physician Services.  122:1156-1162. 2009
  • The Modern Teaching Physician-Responsibilities and Challenges: An APDIM White Paper.  122:692-697. 2009
  • Think, Diagnose, and Rethink.  122:823-826. 2009
  • The Reply.  121. 2008
  • Metformin Use in Polycystic Ovary Syndrome: Metabolic Benefits and Diabetes Prevention.  121. 2008
  • Primary Care of the Patient with Chronic Obstructive Pulmonary Disease-Part 4: Understanding the Clinical Manifestations of a Progressive Disease.  121. 2008
  • Overconfidence as a Cause of Diagnostic Error in Medicine.  121. 2008
  • A True Emergency?.  121:290-292. 2008
  • Randomized Trial to Improve Fracture Prevention in Nursing Home Residents.  120:886-892. 2007
  • Late Diagnosis of HIV Infection: The Role of Age and Sex.  120:370-373. 2007
  • Introduction.  119. 2006
  • Migraines, Angiographic Coronary Artery Disease and Cardiovascular Outcomes in Women.  119:670-675. 2006
  • Academic general internal medicine: Past, present, future.  119:172-175. 2006
  • Exploring the Generalist-Subspecialist Interface in Internal Medicine.  119:528-537. 2006
  • The prophylaxis of medical patients for thromboembolism pilot study.  119:54-59. 2006
  • Commercial support and bias in pharmaceutical research.  117:876-878. 2004
  • The relation of autopsy rate to physicians' beliefs and recommendations regarding autopsy.  117:255-261. 2004
  • Polyneuropathy following gastric bypass surgery [6].  115:679-680. 2003
  • Familial hyperkalemic hypertension: Phenotypic analysis in a large family with the WNK1 deletion mutation.  114:495-498. 2003
  • Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.  115:291-297. 2003
  • Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: The Women's Ischemia Syndrome Evaluation (WISE).  113:723-727. 2002
  • Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: Results from the Iowa Women's Health Study.  112:465-471. 2002
  • Genetic forms of renal potassium and magnesium wasting.  112:235-236. 2002
  • The subspecialty fellowship training program director: essentials and expectations..  112:686-688. 2002
  • Self-help weight loss versus a structured commercial program after 26 weeks: A randomized controlled study.  109:282-287. 2000
  • A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis.  108:301-308. 2000
  • Roles of leukocyte/endothelial cell adhesion molecules in the pathogenesis of vasculitis.  106:677-687. 1999
  • Health status versus quality of life in older patients: Does the distinction matter?.  106:435-440. 1999
  • Meeting the challenges of teaching in ambulatory settings: A national, collaborative approach for internal medicine.  107:193-197. 1999
  • Insulin action and insulin resistance: Diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system.  105:331-345. 1998
  • Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin.  105:91-99. 1998
  • The etiology of obesity: Relative contribution of metabolic factors, diet, and physical activity.  105:145-150. 1998
  • The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections.  104:123-128. 1998
  • Bone marrow biopsy and blood culture in evaluating HIV patients [5] (multiple letters).  105:457-458. 1998
  • Cystic fibrosis: A multiple exocrinopathy caused by dysfunctions in a multifunctional transport protein.  104:576-590. 1998
  • Evaluation of hibernating myocardium in patients with ischemic heart disease.  104:69-77. 1998
  • Taking stock at the green journal.  105:131-134. 1998
  • Low-dose corticosteroid therapy in rheumatoid arthritis: Balancing the evidence.  103. 1997
  • Low-dose corticosteroid therapy in rheumatoid arthritis: balancing the evidence..  103:31S-39S. 1997
  • Predictive factors in rheumatoid arthritis.  103. 1997
  • Predictive factors in rheumatoid arthritis..  103:19S-24S. 1997
  • Prospective evaluation of the gastrointestinal tract in patients with iron deficiency and no systemic or gastrointestinal symptoms or signs.  103:405-409. 1997
  • Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome.  103:223-232. 1997
  • Candidate antiretroviral agents for use in postexposure prophylaxis..  102:25-31. 1997
  • The diagnosis and management of fluid collections associated with pancreatitis.  102:555-563. 1997
  • Etiology of esophageal disease in human immunodeficiency virus-infected patients who fail antifungal therapy.  101:599-604. 1996
  • Arthritis of systemic disease.  101:642-647. 1996
  • Asthma and gastroesophageal reflux: Acid suppressive therapy improves asthma outcome.  100:395-405. 1996
  • Balancing service and education: Improving internal medicine residencies in the managed care era.  100:224-229. 1996
  • Comprehensive geriatric assessment in Medicare managed care: The geriatrician's calling card.  100:383-385. 1996
  • The basis of current and future therapy for inflammatory bowel disease.  100:656-662. 1996
  • A case for an invasion up North?.  98. 1995
  • Contemporary management of acute myocardial infarction.  99:195-206. 1995
  • Cytomegalovirus esophagitis in AIDS: A prospective evaluation of clinical response to ganciclovir therapy, relapse rate, and long-term outcome.  98:169-176. 1995
  • Mechanical ventilation: A review for the internist.  99:553-562. 1995
  • Now who's going to pay for medical students?.  98. 1995
  • Serious adverse events with low-dose, long-term corticosteroid therapy in rheumatoid arthritis.  99:692-693. 1995
  • The reply.  99:693-694. 1995
  • The seductive simplicity of global budgets.  98. 1995
  • Altered pain perception and psychosocial features among women with gastrointestinal disorders and history of abuse: A preliminary model.  97:108-118. 1994
  • Erratum: NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis (American Journal of Medicine (August 1994) 97 (135-144)).  97:497. 1994
  • Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events.  96:115-123. 1994
  • NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis.  97:135-144. 1994
  • Natural history and course of acquired lactic acidosis in adults.  97:47-54. 1994
  • Training the future internal medicine subspecialist.  96:559-561. 1994
  • Doctors, doctors everywhere: The book-movie sequel to follow, next issue.  94. 1993
  • Pandora's administrative box.  94. 1993
  • Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention.  95:315-328. 1993
  • Dentistry: It is safe and medically necessary!.  95:455. 1993
  • Doctors, doctors everywhere: The book-Movie sequel to follow, next issue.  94. 1993
  • Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease.  94:475-482. 1993
  • Got a T. Rex by the tail.  94. 1993
  • Health insurance redux.  95. 1993
  • Primary T-cell lymphoma of muscle in a patient infected with human immunodeficiency virus.  95:545-546. 1993
  • Psychosocial and psychophysical assessments of patients with unexplained chest pain.  92. 1992
  • Psychosocial and psychophysical assessments of patients with unexplained chest pain.  92. 1992
  • Psychosocial and psychophysical assessments of patients with unexplained chest pain..  92:65S-73S. 1992
  • Esophageal disease in the acquired immunodeficiency syndrome: Etiology, diagnosis, and management.  92:412-421. 1992
  • A pilot study of oral corticosteroid therapy for idiopathic esophageal ulcerations associated with human immunodeficiency virus infection.  93:131-134. 1992
  • Asthma severity: a factor analytic investigation.  93:263-269. 1992
  • Charging Peter to examine Paul.  92:4. 1992
  • Erythropoietin in an anephric patient with adrenal medullary hyperplasia.  93:235-236. 1992
  • Hypothyroidism in adults with sickle cell anemia.  92:567-570. 1992
  • Hypothyroidism in adults with sickle cell anemia.  92:567-570. 1992
  • Imported malaria-here to stay.  93:239-242. 1992
  • Itraconazole therapy for blastomycosis and histoplasmosis.  93:489-497. 1992
  • Management of syphilis in human immunodeficiency virus-infected patients.  93:477-479. 1992
  • Diltiazem-cyclosporine interaction in cardiac transplant recipients: impact on cyclosporine dose and medication costs..  90:402-404. 1991
  • STREPTOKINASE THERAPY AND BREAKAWAY PULMONARY EMBOLI - REPLY.  90:412-413. 1991
  • Aerosol pentamidine prophylaxis following pneumocystis carinii pneumonia in AIDS patients: Results of a blinded dose-comparison study using an ultrasonic nebulizer.  90:418-426. 1991
  • Diltiazem-cyclosporine interaction in cardiac transplant recipients: Impact on cyclosporine dose and medication costs.  90:402-404. 1991
  • Improvement in severe onchocercal skin disease after a single dose of ivermectin.  90:590-594. 1991
  • Obesity-related hypertension: Evaluation of the separate effects of energy restriction and weight reduction on hemodynamic and neuroendocrine status.  90:460-468. 1991
  • Refractory hypoxemia in right ventricular infarction from right-to-left shunting via a patent foramen ovale: Efficacy of contrast transesophageal echocardiography.  91:653-655. 1991
  • The reply.  90:412-413. 1991
  • The reply.  90:412-413. 1991
  • A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy.  89:569-578. 1990
  • Clinical findings associated with acute proximal deep vein thrombosis: A basis for quantifying clinical judgment.  88:382-388. 1990
  • Current role of the automatic implantable cardioverter-defibrillator in the treatment of life-threatening ventricular arrhythmias.  88. 1990
  • Cutaneous polyarteritis nodosa.  88:426-430. 1990
  • Cyclosporine-induced changes in glomerular filtration rate and urea excretion.  88:497-502. 1990
  • Cyclosporine-induced changes in glomerular filtration rate and urea excretion.  88:497-502. 1990
  • Failure to limit quantities of benzodiazepine hypnotic drugs for outpatients: Placing the elderly at risk.  89:725-732. 1990
  • Incidence of post-phlebitic syndrome after streptokinase therapy for deep vein thrombosis (Reply).  89:698. 1990
  • J chain disease: A novel form of plasma cell dyscrasia.  88:411-416. 1990
  • Misoprostol in treatment of gastropathy due to nonsteroidal anti-inflammatory drugs.  88:85. 1990
  • Streptokinase therapy for deep vein thrombosis: A comprehensive review of the english literature.  88:389-395. 1990
  • The reply.  89:698. 1990
  • Unsuspected Cushing's disease in a patient with fatal staphylococcal bacteremia and multiple pituitary adenomas..  86:217-221. 1989
  • Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions.  87:153-159. 1989
  • Intrathecal cytosine arabinoside-induced acute, rapidly reversible paralysis.  86:729-730. 1989
  • Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy.  87:144-152. 1989
  • Preoperative lateralization of pituitary microadenomas by petrosal sinus sampling: Utility in two patients with non-ACTH-secreting tumors.  87:679-682. 1989
  • The reply.  86:634. 1989
  • Unsuspected cushing's disease in a patient with fatal staphylococcal bacteremia and multiple pituitary adenomas.  86:217-221. 1989
  • Molecular genetic studies of rheumatoid arthritis.  85:23-25. 1988
  • Restriction fragment length polymorphism analysis in ankylosing spondylitis.  85:48-50. 1988
  • Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.  85:86-105. 1988
  • Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes..  85:86-105. 1988
  • Chronic granulocytic leukemia in a patient with sickle cell anemia.  85:567-569. 1988
  • Treating the older hypertensive patient-an overview.  85:1. 1988
  • Intravenous acyclovir therapy of first episodes of genital herpes: a multicenter double-blind, placebo-controlled trial..  85:301-306. 1988
  • Synergistic nephrotoxicity due to ciprofloxacin and cyclosporine..  85:452-453. 1988
  • Herpes simplex virus infections of the central nervous system. A review..  85:61-67. 1988
  • Azathioprine hypersensitivity. Case report and review of the literature.  84:960-964. 1988
  • Clinically significant valvular heart disease in systemic lupus erythematosus.  85:645-650. 1988
  • Color doppler recognition of left ventricular pseudoaneurysm.  85:432-434. 1988
  • Do not go slowly into that dark night: Mercy killing in Holland.  84:139-141. 1988
  • Do not go slowly into that dark night: mercy killing in Holland..  84:139-141. 1988
  • Evaluation of patients with back pain of suspected inflammatory nature.  85:766-770. 1988
  • Gastrointestinal bleeding in patients receiving long-term anticoagulant therapy.  84:683-690. 1988
  • Herpes simplex virus infections of the central nervous system. A review.  85:61-67. 1988
  • IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?.  84:129-132. 1988
  • Intravenous acyclovir therapy of first episodes of genital herpes: A multicenter double-blind, placebo-controlled trial.  85:301-306. 1988
  • Minimal change glomerulonephropathy and interstitial infiltration with mycosis fungoides.  84:756-759. 1988
  • Myocardial calcification and cardiac dysfunction in chronic renal failure.  85:651-657. 1988
  • On the mechanism by which chloride corrects metabolic alkalosis in man.  84:449-458. 1988
  • Peripheral T-cell lymphoma complicating common variable hypogammaglobulinemia.  85:123-125. 1988
  • Synergistic nephrotoxicity due to ciprofloxacin and cyclosporine.  85:452-453. 1988
  • Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility..  83:1031-1036. 1987
  • Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin.  82:624-629. 1987
  • Brief report: In vitro activity of ciprofloxacin against Neisseria gonorrhoeae.  82:40-41. 1987
  • Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy.  82:703-713. 1987
  • The reply.  83:194-195. 1987
  • Age and the treatment of multiple myeloma. Southeastern Cancer Study Group experience.  79:316-324. 1985
  • Penicillamine-induced Myositis. Observations and unique features in two patients and review of the literature.  77:719-722. 1984
  • Endocytosis by the mononuclear phagocyte system and autoimmune disease.  74:481-493. 1983
  • Reversible "end-stage" lupus nephritis. Analysis of patients able to discontinue dialysis.  74:361-368. 1983
  • Reversible 'end-stage' lupus nephritis. Analysis of patients able to discontinue dialysis.  74:361-368. 1983
  • Mucocutaneous herpes simplex virus infections in immunocompromised patients. A model for evaluation of topical antiviral agents.  73:236-240. 1982
  • Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals.  73:165-171. 1982
  • Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals..  73:165-171. 1982
  • High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus.  70:817-824. 1981
  • Noninvasive diagnosis of mitral prosthesis malfunction.  69:458-462. 1980
  • Bilateral atrial myxomas. Echocardiographic considerations.  65:361-366. 1978
  • Reduction of renal function by newer nonsteroidal anti-inflammatory drugs.  64:804-807. 1978
  • Vancomycin therapy of bacterial endocarditis.  65:411-415. 1978
  • Echocardiography of the aortic root.  62:836-842. 1977
  • Mucosal eosinophilic gastroenteritis with systemic involvement.  62:139-143. 1977
  • Gamma globulin complexes in rheumatoid pericardial fluid.  58:123-128. 1975
  • Thirty-two cases of interventricular septal defect and aortic insufficiency. Clinical, hemodynamic and surgical features.  53:473-480. 1972
  • Left atrial myxoma. Report of a case including hemodynamic, surgical, histologic and histochemical characteristics.  50:113-122. 1971
  • Leukocyte function in chronic granulomatous disease of childhood. Studies on a seventeen year old boy.  47:473-486. 1969
  • Changing patterns of bacterial resistance to antimicrobial drugs.  39:780-795. 1965
  • International Standard Serial Number (issn)

  • 0002-9343
  • Electronic International Standard Serial Number (eissn)

  • 1555-7162